Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects

Journal of Psychopharmacology
E SacchettiG Mazzaglia

Abstract

The purpose of the study was to investigate the risk of stroke with typical and atypical anti-psychotics in elderly subjects, weighting for a number of known risk factors, including dementia. Data were retrospectively drawn from the primary care setting from the Health Search Database, which stores information on about 1.5% of the total Italian population served by general practitioners. All elderly patients (65+ years) prescribed an anti-psychotic in monotherapy from January 2000 to June 2003 were selected for the study. A cohort of patients not exposed to anti-psychotics was taken from the same database. Subjects who had previously had a stroke were excluded. The main outcome measure was the incidence of first-ever stroke during exposure to an anti-psychotic.The sample included non-users (69,939), users of atypicals (599), butyrophenones (749), phenotiazines (907) and substituted benzamides (1,968). The crude incidence of stroke in subjects not exposed to anti-psychotics was 12.0/1000 person-years. Risk was significantly higher for those on butyrophenones (47.1/1000), phenotiazines (72.7/1000) and in the atypical anti-psychotic group (47.4/1000). Substituted benzamides had an almost significant higher risk (25.0/1000). Cox re...Continue Reading

References

Feb 1, 1992·Journal of Clinical Epidemiology·M Von KorffK Saunders
Mar 1, 1987·Fortschritte der Neurologie-Psychiatrie·H SchwalbI Veh-Schindlmayr
Jul 1, 1986·Archives of General Psychiatry·P Allebeck, B Wistedt
Jun 1, 1985·Acta Psychiatrica Scandinavica·O H Brook
Jul 1, 1997·Stroke; a Journal of Cerebral Circulation·R L SaccoP A Wolf
Feb 5, 1999·Seminars in Neurology·M S Elkind, R L Sacco
Oct 21, 1999·Journal of Public Health Medicine·R LawrensonR Farmer
Sep 9, 2000·Schizophrenia Research·U OsbyP Sparén
Dec 21, 2000·Current Atherosclerosis Reports·L B Goldstein
Jan 9, 2001·JAMA : the Journal of the American Medical Association·S C JohnstonS Sidney
Sep 26, 2001·Archives of General Psychiatry·U OsbyP Sparén
Dec 4, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M JoukamaaV Lehtinen
Feb 2, 2002·The American Journal of Psychiatry·Stefan LeuchtWerner Kissling
Jun 14, 2002·Journal of Affective Disorders·F AngstJ Angst
Mar 15, 2003·Stroke; a Journal of Cerebral Circulation·Alessandro FilippiGiampiero Mazzaglia
Jun 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David L GarverJennifer A Holcomb
Sep 23, 2003·Stroke; a Journal of Cerebral Circulation·Perttu J Lindsberg, Armin J Grau
Dec 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·R G McCreadie, UNKNOWN Scottish Schizophrenia Lifestyle Group
May 25, 2004·BMJ : British Medical Journal·Donald MowatTom MacEwan
May 28, 2004·The Journal of Clinical Psychiatry·Suellen M CurkendallJudith K Jones
Jun 1, 2004·The American Journal of Psychiatry·Nathan HerrmannKrista L Lanctôt
Jul 1, 2004·Archives of Internal Medicine·Sabine M J M StrausBruno H C Stricker
Jul 10, 2004·Acta Neurologica Scandinavica·K Wada-IsoeK Nakashima
Aug 11, 2004·Human Psychopharmacology·Sinead M O'BrienTimothy G Dinan
Oct 1, 2004·Journal of Molecular Neuroscience : MN·Tomasz DziedzicAndrzej Szczudlik
Dec 30, 2004·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·M A LeoneF Monaco
Jan 25, 2005·European Journal of Clinical Pharmacology·Gianluca TrifiròGiampiero Mazzaglia
Jan 26, 2005·BMJ : British Medical Journal·Sudeep S GillMuhammad Mamdani
Mar 9, 2005·Neurology·Peter M Rothwell, Charles P Warlow
Aug 5, 2005·Journal of the American Geriatrics Society·Francesc FormigaSebastia Riu
Aug 6, 2005·Stroke; a Journal of Cerebral Circulation·Paul D SymeJohn F Forbes
Sep 15, 2005·Journal of Clinical Psychopharmacology·Mauro PercudaniLorenzo Petrovich
Sep 29, 2005·The Journal of Clinical Psychiatry·Rosa LiperotiRoberto Bernabei

❮ Previous
Next ❯

Citations

Feb 27, 2016·International Journal of Cancer. Journal International Du Cancer·F LapiC Cricelli
Nov 4, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gianluca TrifiròGiovanni Gambassi
Apr 23, 2017·Journal of the American Medical Directors Association·Wan-Ting HsuChien-Chang Lee
Aug 25, 2015·Therapeutic Advances in Psychopharmacology·Selma BozkurtZincirSerkan Zincir
Dec 25, 2010·Pharmacoepidemiology and Drug Safety·Preciosa M ColomaUNKNOWN EU-ADR Consortium
Oct 9, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Pao-Huan ChenChian-Jue Kuo
Apr 27, 2010·Harvard Review of Psychiatry·Lama M ChahineZeina Chemali
Mar 7, 2018·Journal of Psychiatric Practice·Nuria Berrocal-IzquierdoMiguel Bernardo
Mar 20, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emilio SacchettiPaolo Valsecchi
Jan 5, 2012·Psychiatry Investigation·Nina KhachiyantsKye Y Kim
Oct 26, 2013·Journal of Clinical Psychopharmacology·Pietro GareriGiovambattista De Sarro
May 27, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gianluca TrifiróEdoardo Spina
Oct 19, 2016·International Clinical Psychopharmacology·Nuria Berrocal-IzquierdoMiguel Bernardo
Apr 24, 2013·Journal of Clinical Psychopharmacology·Pei-Hua HsiehChurn-Shiouh Gau
Oct 10, 2014·Drug and Therapeutics Bulletin
Oct 1, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gianluca TrifiròGiovanni Corrao
Feb 10, 2011·International Journal of Older People Nursing·Carole ParsonsCarmel Hughes
Aug 14, 2012·International Journal of Geriatric Psychiatry·Julia van de Ven-VakhteevaSytse U Zuidema
Jun 19, 2013·Journal of Clinical Psychopharmacology·Carlotta FranchiAlessandra Marengoni
Jun 3, 2015·Epidemiology·John W JacksonSebastian Schneeweiss
Oct 25, 2020·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Daniel FifeJames Weaver

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.